Skip to main content
SpringerLink
Log in

Comment on: “Patient Perceptions of Opioids and Benzodiazepines and Attitudes Toward Deprescribing”

  • Letter to the Editor
  • Published:
Drugs & Aging Aims and scope Submit manuscript

A Letter to the Editor to this article was published on 02 January 2024

The Original Article was published on 04 October 2023

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kelley CJ, Niznik JD, Ferreri SP, Schlusser C, Armistead LT, Hughes TD, Henage CB, Busby-Whitehead J, Roberts E. Patient perceptions of opioids and benzodiazepines and attitudes toward deprescribing. Drugs Aging. 2023. https://doi.org/10.1007/s40266-023-01071-z. (Epub ahead of print).

    Article  PubMed  Google Scholar 

  2. Langford AV, Gnjidic D, Lin CC, Bero L, Blyth F, Penm J, Schneider CR. “The lesser of two evils”: a framework analysis of consumers’ perspectives on opioid deprescribing and the development of opioid deprescribing guidelines. Pain. 2021;162(11):2686–92. https://doi.org/10.1097/j.pain.0000000000002270.

    Article  PubMed  Google Scholar 

  3. Langford AV, Gnjidic D, Lin CC, Bero L, Penm J, Blyth FM, Schneider CR. Challenges of opioid deprescribing and factors to be considered in the development of opioid deprescribing guidelines: a qualitative analysis. BMJ Qual Saf. 2021;30(2):133–40. https://doi.org/10.1136/bmjqs-2020-010881.

    Article  PubMed  Google Scholar 

  4. Juurlink DN. Rethinking “doing well” on chronic opioid therapy. CMAJ. 2017;189(39):E1222–3. https://doi.org/10.1503/cmaj.170628.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Sullivan MD, Linder JA, Doctor JN. Centers for Disease Control and Prevention Guideline for Prescribing Opioids, 2022—need for integrating dosing benchmarks with shared decision-making. JAMA Intern Med. 2023;183(9):899–900. https://doi.org/10.1001/jamainternmed.2023.2847.

    Article  PubMed  Google Scholar 

  6. Langford AV, Lin CC, Bero L, Blyth FM, Doctor J, Holliday S, Jeon YH, Moullin J, Murnion B, Nielsen S, Osman R, Penm J, Reeve E, Reid S, Wale J, Schneider CR, Gnjidic D. Clinical practice guideline for deprescribing opioid analgesics: summary of recommendations. Med J Aust. 2023;219(2):80–9. https://doi.org/10.5694/mja2.52002.

    Article  PubMed  Google Scholar 

  7. Langford AV, Schneider CR, Lin CC, Bero L, Blyth FM, Doctor J, Holliday S, Jeon YH, Moullin J, Murnion B, Nielsen S, Osman R, Penm J, Reeve E, Reid S, Wale J, Gnjidic D. Evidence-based clinical practice guideline for deprescribing opioid analgesics. The University of Sydney: Sydney. 2022. https://www.opioiddeprescribingguideline.com/guideline. Accessed 16 Oct 2023

  8. Niznik J, Ferreri SP, Armistead L, Urick B, Vest MH, Zhao L, Hughes T, McBride JM, Busby-Whitehead J. A deprescribing medication program to evaluate falls in older adults: methods for a randomized pragmatic clinical trial. Trials. 2022;23(1):256. https://doi.org/10.1186/s13063-022-06164-5.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Farrell B, Pottie K, Rojas-Fernandez CH, Bjerre LM, Thompson W, Welch V. Methodology for developing deprescribing guidelines: using evidence and GRADE to guide recommendations for deprescribing. PLoS ONE. 2016;11(8): e0161248. https://doi.org/10.1371/journal.pone.0161248.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Pottie K, Thompson W, Davies S, Grenier J, Sadowski CA, Welch V, Holbrook A, Boyd C, Swenson R, Ma A, Farrell B. Deprescribing benzodiazepine receptor agonists: evidence-based clinical practice guideline. Can Fam Physician. 2018;64(5):339–51.

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Pharmacy and Pharmaceutical Sciences, Centre for Medicine Use and Safety, Monash University, Parkville, Victoria, Australia

    Aili V. Langford & Emily Reeve

  2. Faculty of Medicine and Health, School of Pharmacy, The University of Sydney, Sydney, NSW, Australia

    Carl R. Schneider & Danijela Gnjidic

  3. Quality Use of Medicines and Pharmacy Research Centre, UniSA: Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia

    Emily Reeve

  4. Sol Price School of Public Policy, University of Southern California, California, USA

    Jason N. Doctor

Authors
  1. Aili V. Langford
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carl R. Schneider
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Emily Reeve
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jason N. Doctor
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Danijela Gnjidic
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Aili V. Langford.

Ethics declarations

Funding

Dr E Reeve is funded by a National Health and Medical Research Council (NHMRC) Investigator Grant (1195460). Associate Professor D Gnjidic is supported by The University of Sydney Thompson Fellowship. The funding sources were not involved in study design; in the collection, analysis and interpretation of data; in the writing of the manuscript; and in the decision to submit the article for publication.

Conflict of interest

Dr Reeve receives royalties from UpToDate (Wolters Kluwer) for writing a chapter on deprescribing.

Authors contributions

AVL, CRS and DG conceived the letter and wrote the first draft of the manuscript. ER and JD critically revised subsequent drafts for important intellectual content. All authors approved the manuscript and agree to be accountable for its content.

Consent (participation & publication)

Not applicable.

Data availability

Data sharing is not applicable to this article, as no datasets were generated or analysed during the current study.

Code availability

Not applicable.

Ethics approval

Not applicable.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Langford, A.V., Schneider, C.R., Reeve, E. et al. Comment on: “Patient Perceptions of Opioids and Benzodiazepines and Attitudes Toward Deprescribing”. Drugs Aging 41, 77–78 (2024). https://doi.org/10.1007/s40266-023-01086-6

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40266-023-01086-6

Search

Navigation